A detailed history of Activest Wealth Management transactions in Moderna, Inc. stock. As of the latest transaction made, Activest Wealth Management holds 1,324 shares of MRNA stock, worth $52,152. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,324
Previous 3,424 61.33%
Holding current value
$52,152
Previous $406,000 78.33%
% of portfolio
0.03%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$63.64 - $125.14 $133,644 - $262,794
-2,100 Reduced 61.33%
1,324 $88,000
Q2 2024

Jul 30, 2024

BUY
$101.21 - $166.61 $325,187 - $535,317
3,213 Added 1522.75%
3,424 $406,000
Q4 2023

Jan 19, 2024

SELL
$69.51 - $104.43 $1,390 - $2,088
-20 Reduced 8.66%
211 $20,000
Q3 2023

Oct 10, 2023

SELL
$96.41 - $126.61 $30,754 - $40,388
-319 Reduced 58.0%
231 $23,000
Q2 2023

Jul 21, 2023

BUY
$118.5 - $160.53 $36,972 - $50,085
312 Added 131.09%
550 $66,000
Q1 2023

Apr 18, 2023

SELL
$135.66 - $197.02 $130,640 - $189,730
-963 Reduced 80.18%
238 $36,000
Q4 2022

Jan 18, 2023

SELL
$118.38 - $210.04 $7,457 - $13,232
-63 Reduced 4.98%
1,201 $0
Q3 2022

Oct 13, 2022

BUY
$118.07 - $194.18 $121,139 - $199,228
1,026 Added 431.09%
1,264 $159,000
Q1 2022

Apr 26, 2022

SELL
$126.46 - $235.05 $14,289 - $26,560
-113 Reduced 32.19%
238 $41,000
Q4 2021

Jan 13, 2022

BUY
$225.82 - $368.51 $15,581 - $25,427
69 Added 24.47%
351 $89,000
Q3 2021

Oct 12, 2021

SELL
$221.9 - $484.47 $29,290 - $63,950
-132 Reduced 31.88%
282 $109,000
Q2 2021

Sep 20, 2021

SELL
$129.91 - $234.98 $28,450 - $51,460
-219 Reduced 34.6%
414 $97,000
Q1 2021

Sep 20, 2021

BUY
$109.18 - $185.98 $69,110 - $117,725
633 New
633 $83,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Activest Wealth Management Portfolio

Follow Activest Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Activest Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Activest Wealth Management with notifications on news.